Inhibition of apoptosis, activation of NKT cell and upregulation of CD40 and CD40L mediated by M. leprae antigen(s) combined with Murabutide and Trat peptide in leprosy patients

Molecular and Cellular Biochemistry

Volumn 309, Issue 1-2, 2008, Pages 87-97

  Chattree, Vineeta ^a   Khanna, Neena ^a   Bisht, Vandana ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; CD40 CD40L; Fas FasL; Immunomodulators; Liposomes; M. leprae antigen; Natural killer T cells

Indexed keywords

BACTERIAL ANTIGEN; CASPASE 3; CASPASE 8; CD40 ANTIGEN; CD40 LIGAND; FAS ANTIGEN; FAS LIGAND; IMMUNOMODULATING AGENT; LEPROSY VACCINE; LIPOSOME; MANNOSE CAPPED LIPOARABINOMANNAN; MURABUTIDE; MYCOBACTERIUM LEPRAE TOTAL CELL WALL ANTIGEN; PROPIDIUM IODIDE; PROTEIN BCL XL; PROTEIN TRAT; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEPROSY; MALE; MYCOBACTERIUM LEPRAE; NATURAL KILLER CELL; T LYMPHOCYTE; UPREGULATION;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADULT; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, CD40; APOPTOSIS; BCL-X PROTEIN; CASPASE 3; CASPASE 8; CD40 LIGAND; CYTOKINES; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; KILLER CELLS, NATURAL; LEPROSY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; PROPIDIUM; UP-REGULATION;

MYCOBACTERIUM LEPRAE;

EID: 38649127600     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9646-8     Document Type: Article

References (41)

1. Choudhuri K (1995) The immunology of leprosy; unraveling an enigma. Int J Lepr Other Mycobact Dis 63:430-447
2. Yamamura M, Uyemura K, Deans RJ et al (1991) Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 254:277-279
3. Sieling PA, Abrams JS, Yamamura M et al (1993) Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 150:5501-5510
4. Groux H, Bigler M, de Vries JE et al (1996) Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184:1-8
5. Flores Villanueva PO, Reiser H, Stadecker MJ (1994) Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7-1 and B7-2 costimulatory molecules by macrophages. J Immunol 153:5190-5199
6. Keane J, Shurtleff B, Kornfeld H (2002) TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner. Tuberculosis 82:55-61
7. Gupta A, Sharma VK, Voha H et al (1999) Inhibition of apoptosis by ionomycin and zinc in peripheral blood mononuclear cells (PBMCs) of leprosy patients. Clin Exp Immunol 117:56-62
8. Gupta A, Sharma VK, Voha H et al (1999) Spontaneous apoptosis in peripheral blood mononuclear cells of leprosy patients: Role of cytokines. FEMS. Immunol Med Microbiol 24:49-55
9. Klingler K, Tchou-Wong KM, Brandli O et al (1997) Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes. Infect Immun 5:5272-5278
10. Ellner JJ, Daniel TM (1979) Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol 35:250-257
11. Molloy A, Gaudernack G, Levis WR et al (1990) Suppression of T-cell proliferation by Mycobacterium leprae and its products: The role of lipopolysaccharide. Proc Natl Acad Sci USA 87:973-977
12. Sridevi K, Khanna N, Chattree V et al (2003) Reversal of T cell anergy in leprosy patients: In vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery Int Immunopharmacol 3:1589-1600
13. Chedid LA, Parant MA, Audibert FM et al (1982) Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity. Infect Immun 35:417-424
14. Tindle RW, Croft S, Herd K et al (1995) A vaccine conjugate of 'SCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clin Exp Immunol 101:265-271
15. Sridevi K, Khanna N, Chitralekha KT et al (2004) Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein. Int Immunopharmacol 4:1-14
16. Chattree V, Khanna N, Rao DN (2007) Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients. Mol Immunol 44:2076-2087
17. Durie FH, Foy TM, Masters SR et al (1994) The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 15:406-411
18. L expression protects CD40-activated human B cells from Fas-mediated apoptosis. Cell Immunol 173:49-154
19. Bendelac A, Rivera MN, Park SH et al (1997) Mouse CD1-specific NK1T cells: Development, specificity, and function. Annu Rev Immunol 15:535-562
20. Mercer JC, Ragin MJ, August A (2005) Natural killer T cells: Rapid responders controlling immunity and disease. Int J Biochem Cell Biol 37:1337-1343
21. Seino K, Motohashi S, Fujisawa T et al (2006) Natural killer T cell-mediated antitumor immune responses and their clinical applications. Cancer Sci 97:807-812
22. Ronet C, Darche S, Leite de Moraes M et al (2005) NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. J Immunol 175:899-908
23. Arrunategui-Correa V, Lenz L, Kim HS (2004) CD1d-independent regulation of NKT cell migration and cytokine production upon Listeria monocytogenes infection. Cell Immunol 232:38-48
24. Apostolou I, Takahama Y, Belmant C et al (1999) Murine natural killer T (NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA 96:5141-5146
25. Ridley DS, Jopling WH (1966) Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34:255-273
26. Turanek J, Toman M, Novak J et al (1994) Adjuvant effect of liposomes and adamantylamide dipeptide on antigenicity of entrapped synthetic peptide derived from HIV-I transmembrane region glycoprotein gp41. Immunol Lett 39:157-161
27. Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97:77-89
28. Thornberry NA (1994) Interleukin-1 beta converting enzyme. Methods Enzymol 244:615-631
29. Mauro O, Toufic R, Antine A et al (1998) Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 160:5448-5454
30. Noel PJ, Boise LH, Green JM et al (1996) CD28 costimulation prevents cell death during primary T cell activation. J Immunol 157:636-642
31. L. Immunity 3:87-98
32. Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111-135
33. Campbell KA, Ovendale PJ, Kennedy MK et al (1996) CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283-289
34. Kamanaka M, Yu P, Yasui T et al (1996) Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275-281
35. Borrow P, Tishon A, Lee S et al (1996) CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med 183:2129-2142
36. Yamauchi PS, Bleharski JR, Uyemura K et al (2000) A role for CD40-CD40 Ligand interactions in the generation of type I cytokine responses in human leprosy. J Immunol l165:1506-1512
37. Lee BO, Haynes L, Eaton SM et al (2002) The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. J Exp Med 5:693-704
38. Ding L, Green JM, Thompson CB et al (1995) B7/CD28-dependent and indepenent induction of CD 40 ligand expression. J Immunol 155:5124-5132
39. Johnson-Leger C, Chistenson JR, Holamn M et al (1998) Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells. J Immunol 161:4618-4626
40. Thomssen H, Kahan M, Londei M (1995) Differential effects of interleukin-10 on the expression of HLA class II and CD1 molecules induced by granulocytes/macrophage colony-stimulating factor/ interleukin-4. Eur J Immunol 25:2465-2470
41. Hayakawa Y, Takeda K, Yagita H et al (2001) Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol 166:6012-6018